Wordt geladen...
BLT2, a leukotriene B(4) receptor 2, as a novel prognostic biomarker of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is considered to be a notorious type of cancer due to its aggressive metastatic potential and poor prognosis. Recent evidence suggests that BLT2, a low-affinity LTB(4) receptor is critically associated with the phenotypes of TNBC cells, including invasion, metast...
Bewaard in:
| Gepubliceerd in: | BMB Rep |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Korean Society for Biochemistry and Molecular Biology
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6130834/ https://ncbi.nlm.nih.gov/pubmed/29898809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2018.51.8.127 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|